Mouse over to pause the slideshow, mouse-off to resume.

Orthogem's patented Technology Platform has enabled the creation of a pipeline of SBGs for a variety of clinical applications from spinal to Oral Cranial Facial surgery. Orthogem's novel, complex multiporous structure achieves rapid bone remodelling through enhanced osteoconductive and bioactive properties.

Orthogem is set apart by the quality and depth of its preclinical scientific data demonstrating that its proprietary technology can deliver significantly superior results in comparison to established major players in the SBG sector.

Synthetic bone substitutes have been in use for twenty years and failed to replace surgeons' preference for autograft despite associated morbidity and cost. Orthogem's new Technology Platform is a new generation SBG that has demonstrated the preclinical performance required to challenge autograft.